{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:15:20Z","timestamp":1778728520176,"version":"3.51.4"},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T00:00:00Z","timestamp":1323043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Introduction and Aims.<\/jats:bold>  <jats:italic>In Australia, people who inject drugs (PWID) commonly report the use of benzodiazepines (BZDs). This paper explores the emerging use of alprazolam among PWID in Melbourne, Australia.<\/jats:italic><\/jats:p><jats:p><jats:bold>Design and Methods.<\/jats:bold>  <jats:italic>This study reports on 3\u2003years of data collected through the Victorian Illicit Drug Reporting System (2008\u20132010). Structured interviews were conducted with 451 PWID and analysed using odds ratios and \u03c7<jats:sup>2<\/jats:sup>\u2010tests for trends over time.<\/jats:italic><\/jats:p><jats:p><jats:bold>Results.<\/jats:bold>  <jats:italic>While the proportion of PWID reporting recent BZD use remained stable over time, the proportion reporting alprazolam to be their most commonly used BZD fluctuated, peaking in 2009. Alprazolam users were significantly more likely to report using illicit BZDs and to report recent BZD injection compared with users of other BZDs. Alprazolam use was associated with the sale of drugs for cash, but not with other criminal activities.<\/jats:italic><\/jats:p><jats:p><jats:bold>Discussion and Conclusion.<\/jats:bold>  <jats:italic>The fluctuations in alprazolam use over time may be reflective of medical practitioners ceasing to prescribe alprazolam in response to reports of associated harms; however, this may in turn be driving the illicit alprazolam market. While the data do not indicate a clear association between alprazolam use and harms, considering the potential severity of associated harms and the association between alprazolam use and anterograde amnesia, patterns of alprazolam use among PWID should be closely monitored. Potential changes to prescribing practice should consider unintended consequences, such as replacement with other BZD types, or illicitly obtained BZDs.<\/jats:italic>[Horyniak D, Reddel S, Quinn B, Dietze P. The use of alprazolam by people who inject drugs in Melbourne, Australia. <jats:italic>Drug Alcohol Rev<\/jats:italic> 2012;31:585\u2013590]<\/jats:p>","DOI":"10.1111\/j.1465-3362.2011.00381.x","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T04:55:00Z","timestamp":1323147300000},"page":"585-590","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The use of alprazolam by people who inject drugs in Melbourne, Australia"],"prefix":"10.1111","volume":"31","author":[{"given":"DANIELLE","family":"HORYNIAK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SIOBHAN","family":"REDDEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BRENDAN","family":"QUINN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAUL","family":"DIETZE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,12,5]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952998809020204"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540260500071863"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.01.011"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230220119318"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb126051.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/0959523021000023225"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2010.00533.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-4-16"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.12.007"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6936.1082"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90092-5"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v10n03_02"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.03.008"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90093-6"},{"key":"e_1_2_7_16_2","first-page":"143","article-title":"[Benzodiazepine use in a sample of patients on a treatment program with opiate derivatives (PTDO)]","volume":"21","author":"Fernandez Sobrino AM","year":"2009","journal-title":"Adicciones"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.09.004"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01094.x"},{"key":"e_1_2_7_19_2","volume-title":"Benzodiazepine and pharmaceutical opioid misuse and their relationship to crime: an examination of illicit prescription drug markets in Melbourne, Hobart and Darwin","author":"Fry C","year":"2007"},{"key":"e_1_2_7_20_2","volume-title":"Australian drug trends 2009: findings from the Illicit Drug Reporting System (IDRS)","author":"Stafford J","year":"2010"},{"key":"e_1_2_7_21_2","volume-title":"Australian drug trends 2008: findings from the Illicit Drug Reporting System (IDRS)","author":"Stafford J","year":"2009"},{"key":"e_1_2_7_22_2","volume-title":"Australian drug trends 2007: findings from the Illicit Drug Reporting System (IDRS)","author":"Black E","year":"2008"},{"key":"e_1_2_7_23_2","volume-title":"Victorian drug trends 2009: findings from the Illicit Drug Reporting System (IDRS)","author":"Horyniak D","year":"2010"},{"key":"e_1_2_7_24_2","volume-title":"Victorian drug trends 2008: findings from the Illicit Drug Reporting System (IDRS)","author":"Quinn B","year":"2009"},{"key":"e_1_2_7_25_2","unstructured":"UBM Medica.MIMS Online.2011. Available at:http:\/\/www.mims.com\/USA\/drug\/info\/alprazolam\/(accessed 3 August 2011)."},{"key":"e_1_2_7_26_2","unstructured":"Medicare Australia.Pharmaceutical Benefits Scheme.2011. Available at:https:\/\/www.medicareaustralia.gov.au\/statistics\/pbs_item.shtml(accessed 1 March 2011)."},{"key":"e_1_2_7_27_2","volume-title":"Panic disorder and agoraphobia: Australian treatment guide for consumers and carers","author":"The Royal Australian and New Zealand College of Psychiatrists","year":"2009"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00310-X"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800290037005"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.2.276b"},{"key":"e_1_2_7_31_2","first-page":"463","article-title":"Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam","volume":"27","author":"DeVane CL","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700029056"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2265-8"},{"key":"e_1_2_7_34_2","volume-title":"Investigation of pharmaceutical misuse amongst drug treatment clients","author":"Nielsen S","year":"2008"},{"key":"e_1_2_7_35_2","unstructured":"Medical Practitioners Board of Victoria.Warning: Alprazolam (Xanax Kalma Zamhexsal) Bulletin. June2009 page 11."},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.3109\/16066359808993294"},{"key":"e_1_2_7_37_2","unstructured":"Australian Bureau of Statistics.Regional Population Growth Australia Report 3218.0.2010. Available at:http:\/\/www.abs.gov.au\/ausstats(accessed 1 March 2011)."},{"key":"e_1_2_7_38_2","unstructured":"De GraaffB BrunoR.Alprazolam use in Tasmania: is policy change kicking goals or behinds?APSAD Conference; Canberra Australia 2010."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1996.9134059.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.07.009"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9357016.x"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.11.007"},{"key":"e_1_2_7_43_2","volume-title":"Heroin deaths in Victoria 2007\/2008","author":"Woods J","year":"2009"},{"key":"e_1_2_7_44_2","unstructured":"RintoulAC NielsenS DrummerOH DobbinM.Benzodiazepine supply and heroin\u2010related deaths in Victoria: the success of flunitrazepam regulation compared with escalating deaths involving alprazolam. APSAD Conference; Canberra Australia 2010."},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(95)00053-4"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1465-3362.2011.00381.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1465-3362.2011.00381.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T16:23:01Z","timestamp":1698769381000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1465-3362.2011.00381.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,5]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1465-3362.2011.00381.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1465-3362.2011.00381.x","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,5]]},"assertion":[{"value":"2011-12-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}